4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
LENZ Therapeutics, Inc. (LENZ) operates in the Biotechnology industry and is headquartered in Solana Beach, United States with about 152 employees. Its market capitalization is roughly $162 million. In the fiscal year ended 2025-12-31, LENZ reported $19M in revenue and ($82M) in net income.
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc.
Interactive charts & full statements → Open the LENZ valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $19M | $0M | $0M | $15M |
| Gross Profit | $19M | $0M | — | — |
| Operating Income (EBIT) | ($91M) | ($59M) | ($72M) | ($10M) |
| Net Income | ($82M) | ($50M) | ($70M) | ($11M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $2M | $2M | $12M | $5M | $0M |
| Gross Profit | $1M | — | — | — | $0M |
| Operating Income (EBIT) | ($44M) | ($38M) | ($19M) | ($17M) | ($17M) |
| Net Income | ($42M) | ($36M) | ($17M) | ($15M) | ($15M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $306M | $215M | $70M | $47M | — |
| Total Liabilities | $22M | $11M | $163M | $71M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LENZ viewer.
About TickerBase · Data methodology & sources